Some wear sunglasses indoors, apply cold vinegar compresses or chew on ginger. Others sit in the dark for days. But there’s one thing most migraine sufferers agree on: the pharma industry has failed them.
Four drugmakers are working to fix that by bringing to market the first generation of drugs developed to prevent migraines. The products, designed to target a peptide known to touch off the pain attacks, all have blockbuster potential.